These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 9385282
1. A double blind study of intranasal calcitonin for established postmenopausal osteoporosis. Kapetanos G, Symeonides PP, Dimitriou C, Karakatsanis K, Potoupnis M. Acta Orthop Scand Suppl; 1997 Oct; 275():108-11. PubMed ID: 9385282 [Abstract] [Full Text] [Related]
2. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study. Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K. Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969 [Abstract] [Full Text] [Related]
4. Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin. Adami S, Baroni MC, Broggini M, Carratelli L, Caruso I, Gnessi L, Laurenzi M, Lombardi A, Norbiato G, Ortolani S. Osteoporos Int; 1993 Jun; 3 Suppl 3():S21-7. PubMed ID: 8298199 [Abstract] [Full Text] [Related]
6. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study. Chesnut CH, Majumdar S, Newitt DC, Shields A, Van Pelt J, Laschansky E, Azria M, Kriegman A, Olson M, Eriksen EF, Mindeholm L. J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627 [Abstract] [Full Text] [Related]
7. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin. Tascioglu F, Colak O, Armagan O, Alatas O, Oner C. Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191 [Abstract] [Full Text] [Related]
8. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss. Reginster JY, Deroisy R, Lecart MP, Sarlet N, Zegels B, Jupsin I, de Longueville M, Franchimont P. Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123 [Abstract] [Full Text] [Related]
15. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Chesnut CH, Silverman S, Andriano K, Genant H, Gimona A, Harris S, Kiel D, LeBoff M, Maricic M, Miller P, Moniz C, Peacock M, Richardson P, Watts N, Baylink D. Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576 [Abstract] [Full Text] [Related]
16. Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture. Huusko TM, Karppi P, Kautiainen H, Suominen H, Avikainen V, Sulkava R. Calcif Tissue Int; 2002 Dec; 71(6):478-84. PubMed ID: 12370798 [Abstract] [Full Text] [Related]
17. Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women. Downs RW, Bell NH, Ettinger MP, Walsh BW, Favus MJ, Mako B, Wang L, Smith ME, Gormley GJ, Melton ME. J Clin Endocrinol Metab; 2000 May; 85(5):1783-8. PubMed ID: 10843152 [Abstract] [Full Text] [Related]
18. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D. J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265 [Abstract] [Full Text] [Related]
19. Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis. Thamsborg G, Jensen JE, Kollerup G, Hauge EM, Melsen F, Sorensen OH. Bone; 1996 Feb; 18(2):207-12. PubMed ID: 8833216 [Abstract] [Full Text] [Related]
20. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment. Overgaard K, Hansen MA, Nielsen VA, Riis BJ, Christiansen C. Am J Med; 1990 Jul; 89(1):1-6. PubMed ID: 2152594 [Abstract] [Full Text] [Related] Page: [Next] [New Search]